
Nasus Pharma Ltd.
CEO
Dan Teleman
IPO Date
2025-08-13
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
AMEX
Country
IL
| 2,900 |
| $3.76 |
| 1 Apr 2026 | Teleman Dan Benjamin | director, officer: Chief Executive Officer | P-Purchase | Acquired | 15,000 | $2.04 |
| 27 Mar 2026 | Rubin Eyal | officer, other: Chief Financial Officer | Disposed | 40,549 | $7.56 |
| 27 Mar 2026 | Silberman David | director | Disposed | 10,000 | $5.38 |
| 27 Mar 2026 | Teleman Dan Benjamin | director, officer: Chief Executive Officer | Disposed | 0 | $0.00 |
| 27 Mar 2026 | Teleman Dan Benjamin | director, officer: Chief Executive Officer | Disposed | 318,856 | $6.05 |
| 27 Mar 2026 | Shacham Sharon | director | Disposed | 10,000 | $5.38 |
| 27 Mar 2026 | Gilboa Udi | other: Founder & Executive Chairman | Disposed | 0 | $0.00 |
| 27 Mar 2026 | Gilboa Udi | other: Founder & Executive Chairman | Disposed | 0 | $0.00 |